Q&A With Paul Hudson of AstraZeneca US: ADA Meeting Provides Unique Look at Diabetes Field

With more than 10000 people in Boston for the American Diabetes Association's Scientific Sessions the event provides a chance for some of the top minds in the field to share information.

With more than 10000 people in Boston for the American Diabetes Association's Scientific Sessions the event provides a chance for some of the top minds in the field to share information.

Paul Hudson, President of AstraZeneca US discussed some of the areas of focus of the meeting which was held in Boston this year. Hudson said topics discussed include the latest technology and medicine as well as ways to control costs so patients can afford the treatment they need.